S. J. Ingle and K. K. Tapar, “QSAR and Docking Studies on 1,2-benzisoxazole Derivatives for Antipsychotic activity against Dopamine receptor (D2)”, Cur Res Pharm Sci, vol. 6, no. 2, pp. 31-34, Jul. 2016.